Literature DB >> 30043745

Changes to dolutegravir policy in several African countries.

Esther Nakkazi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30043745     DOI： 10.1016/S0140-6736(18)31641-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Authors:  Alan N Engelman
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

2.  Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework.

Authors:  Françoise Renaud; Lynne M Mofenson; Charlotte Bakker; Helen Dolk; Valeriane Leroy; Angelina Namiba; Leyla Sahin; Roger Shapiro; Amy Slogrove; Claire Thorne; Marissa Vicari; Daniel Low-Beer; Meg Doherty
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

3.  Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1.

Authors: 
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

4.  Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.

Authors:  Lynne M Mofenson; Anton L Pozniak; Jacque Wambui; Elliot Raizes; Andrea Ciaranello; Polly Clayden; Peter Ehrenkranz; Ade Fakoya; Andrew Hill; Saye Khoo; Imelda Mahaka; Surbhi Modi; Cynthia Moore; Andrew Phillips; George Siberry; Kenly Sikwese; Claire Thorne; Heather D Watts; Meg Doherty; Nathan P Ford
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

5.  Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda.

Authors:  Leah Mbabazi; Mariah Sarah Nabaggala; Suzanne Kiwanuka; Juliet Kiguli; Eva Laker; Arthur Kiconco; Stephen Okoboi; Mohammed Lamorde; Barbara Castelnuovo
Journal:  BMC Womens Health       Date:  2022-06-27       Impact factor: 2.742

6.  Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?

Authors:  Lee Fairlie; Catriona Waitt; Shahin Lockman; Michelle Moorhouse; Elaine J Abrams; Polly Clayden; Marta Boffito; Saye Khoo; Helen Rees; Amandine Cournil; Willem Francois Venter; Celicia Serenata; Matthew Chersich
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396

7.  The Prevalence and Associated Factors of Hypertension among HIV Patients.

Authors:  Grace Wambura Mbuthia; Karani Magutah; Stephen T McGarvey
Journal:  Int J Hypertens       Date:  2021-04-15       Impact factor: 2.420
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.